Authors
Loading...
Randomized trial explores immune cells' impact on osteoarthritis severity, suggesting CCL19 as a therapeutic target.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: